Professor of Developmental Neuroscience at University of Oxford
Distribution of T14 in the brain developing and adult rodents with microscopy.

Deputy Director of the Mass Spectrometry Centre at University of Sheffield
Detection of T14 in blood/brain/CSF using Mass Spectrometry

Associate Professor at University of Nottingham.
Novel animal model of Alzheimer’s (T30).

Professor of Neuropharmacology at Oxford Brookes University.
Target engagement: characterisation of the binding of the peptide and drugs on the alpha7 nicotinic receptor.

Associate Professor in Chemical-Biology and Director of the Centre for Global Infectious Diseases at Durham University.
Drug discovery: peptoid and peptide chemistry to tackle interesting and challenging biological problems. He is a valued member of our Drug Risk Task Force.

Professor of Medicine and Neurology at University of California, Los Angeles
Alzheimer’s: Proof of concept and characterisation of NBP14 in pathology

Professor of Neuroscience at University of Oxford
Parkinson’s: Effects of T30 and NBP14 on dopamine release ex vivo.

Principal Investigator at Universidad Miguel Hernández de Elche
Proof of concept: Comparison of rat embryo brains with pathology

Clinical Senior Lecturer in Neurology at Queens Mary, University of London
ALS: Relation of plasma T14 to pathology.

Principal Investigator at Universidad Miguel Hernández de Elche
Proof of concept: Comparison of rat embryo brains with AD pathology.

Non-Clinical Lecturer at Sheffield University
ALS: Effects of T30 and NBP14 in zebrafish model.